60 Degrees Pharmaceuticals Inc (SXTP)

Currency in USD
1.270
-0.010(-0.78%)
Closed·
1.260-0.010(-0.76%)
·
SXTP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SXTP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2601.300
52 wk Range
0.4514.420
Key Statistics
Prev. Close
1.28
Open
1.28
Day's Range
1.26-1.3
52 wk Range
0.451-4.42
Volume
36.45K
Average Volume (3m)
627.39K
1-Year Change
-18.59%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SXTP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

60 Degrees Pharmaceuticals Inc Company Profile

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.

Employees
3

Compare SXTP to Peers and Sector

Metrics to compare
SXTP
Peers
Sector
Relationship
P/E Ratio
0.0x−0.1x−0.6x
PEG Ratio
0.000.010.00
Price/Book
0.0x1.1x2.6x
Price / LTM Sales
0.0x1.6x3.3x
Upside (Analyst Target)
0.0%107.8%39.5%
Fair Value Upside
Unlock17.7%4.9%Unlock

Earnings

Latest Release
Aug 21, 2025
EPS / Forecast
-1.26 / -0.10
Revenue / Forecast
307.87K / --
EPS Revisions
Last 90 days

SXTP Income Statement

People Also Watch

2.36
INMB
-1.67%
2.200
VOR
+7.32%
0.110
WINT
-77.27%
3.6100
SNGX
-2.43%
5.3300
BGLC
+0.19%

FAQ

What Stock Exchange Does 60 Degrees Pharmaceuticals Trade On?

60 Degrees Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for 60 Degrees Pharmaceuticals?

The stock symbol for 60 Degrees Pharmaceuticals is "SXTP."

What Is the 60 Degrees Pharmaceuticals Market Cap?

As of today, 60 Degrees Pharmaceuticals market cap is 29.52M.

What Is 60 Degrees Pharmaceuticals's Earnings Per Share (TTM)?

The 60 Degrees Pharmaceuticals EPS (TTM) is -7.90.

When Is the Next 60 Degrees Pharmaceuticals Earnings Date?

60 Degrees Pharmaceuticals will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is SXTP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has 60 Degrees Pharmaceuticals Stock Split?

60 Degrees Pharmaceuticals has split 0 times.

How Many Employees Does 60 Degrees Pharmaceuticals Have?

60 Degrees Pharmaceuticals has 3 employees.

What is the current trading status of 60 Degrees Pharmaceuticals (SXTP)?

As of 21 Aug 2025, 60 Degrees Pharmaceuticals (SXTP) is trading at a price of 1.27, with a previous close of 1.28. The stock has fluctuated within a day range of 1.26 to 1.30, while its 52-week range spans from 0.45 to 4.42.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.